GlassScriptPhysician profile
Sudhendu Choubey
NPI 1104827088
$25,220.24
in general payments reported to CMS, 2019-2025
40 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,907 · 2020: $5,369 · 2021: $3,203 · 2022: $2,579 · 2023: $2,255 · 2024: $1,696 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,161.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9,819.97 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,604.82 | 2019-2024 | Xarelto |
| Irhythm Technologies, INC. | $1,417.59 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $1,307.09 | 2019-2025 | |
| Amgen INC. | $1,054.14 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,038.88 | 2019-2025 | Brilinta, Farxiga |
| Medtronic, INC. | $842.77 | 2021-2023 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $646.71 | 2021-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $638.70 | 2019-2022 | |
| Amarin Pharma, INC. | $583.28 | 2019-2023 | |
| Esperion Therapeutics, INC. | $559.01 | 2020-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $556.56 | 2021-2025 | |
| Medtronic Vascular, INC. | $514.36 | 2019-2020 | |
| Inspire Medical Systems, INC. | $490.67 | 2023-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $480.38 | 2019-2025 | Jardiance |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $384.18 | 2020-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Abbott Laboratories | $382.23 | 2020-2023 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| United Therapeutics Corporation | $379.39 | 2023-2025 | Tyvaso, Tyvaso |
| Kiniksa Pharmaceuticals, LTD. | $285.70 | 2021-2023 | Arcalyst |
| Pfizer INC. | $265.46 | 2019-2025 | |
| Astellas Pharma US INC | $261.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $234.58 | 2019 | |
| Novo Nordisk INC | $218.78 | 2023-2025 | Ozempic, Wegovy |
| Lexicon Pharmaceuticals, INC. | $215.91 | 2023-2024 | Inpefa |
| Abiomed | $173.45 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $172.12 | 2019-2022 | |
| Lundbeck LLC | $111.84 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $86.28 | 2019 | |
| Baxter Healthcare | $85.98 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $78.93 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $70.24 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $56.79 | 2021 | |
| Medicure Pharma INC. | $43.84 | 2021 | |
| Preventice Services, LLC | $31.90 | 2021 | |
| Vifor Pharma, INC. | $31.33 | 2019-2021 | |
| Philips North America LLC | $30.85 | 2025 | Mechanical Tools |
| Phathom Pharmaceuticals, INC. | $26.33 | 2025 | Voquezna |
| Itamar Medical INC | $17.12 | 2025 | Watchpatone |
| Tactile Systems Technology INC | $13.73 | 2021 | |
| Edwards Lifesciences Corporation | $7.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudhendu Choubey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.